Virginia 2026 1st Special Session

Virginia House Bill HB1040

Caption

An Act to amend and reenact §§ 23.1-2402 and 23.1-2403 of the Code of Virginia, relating to Virginia Commonwealth University Health System Authority; board of directors; chief executive officer.

Summary

HB1040 revises the governance structure of the Virginia Commonwealth University Health System Authority by changing the composition, appointment process, and terms of its board of directors. The bill reduces the board from 21 members to 16, lowers the number of appointed members from 19 to 13, and changes the mix of gubernatorial, legislative, and university-affiliated appointees. It also adjusts the number of physician-faculty members, modifies how those physician-faculty nominees are selected, and changes board terms from three years to four years. The bill also updates board leadership rules. It provides that the president of the University serves ex officio without voting privileges, while the Senior Vice-President for Health Sciences and the chief executive officer of the Authority serve ex officio with voting privileges. It continues to require that appointed members have relevant experience in business, commercial real estate, finance, health care system management, or legal affairs, and it preserves restrictions intended to ensure a majority of the board has no direct affiliation with the University or Authority. The bill further changes the board’s internal officer structure by making the board elect its chair and vice-chair biennially rather than annually, while keeping the president of the University in a separate role as board chairman under the statute’s framework. In practical terms, the bill amends §§ 23.1-2402 and 23.1-2403 of the Code of Virginia and directly affects the governance and oversight of VCU Health System Authority. It changes who may serve on the board, how long they serve, how vacancies are filled, and how leadership is selected, which can affect decision-making, institutional oversight, and the balance between university control and independent governance. Because the measure was enacted as Chapter 444, it becomes part of Virginia law governing the Authority. The overall sentiment reflected by the available record is neutral to favorable toward restructuring the board, with no recorded committee transcript or vote opposition in the provided materials. The bill appears to be a technical but substantive governance update rather than a controversial policy change. The main policy tension inherent in the text is between maintaining university and physician-faculty representation and increasing the proportion of outside, non-affiliated members to preserve independent oversight. Notable points of contention, based on the statutory changes themselves, would likely center on the reduced board size, the decreased number of physician-faculty seats, and the shift in appointment power among the Governor, House Speaker, Senate Rules Committee, and the University’s board of visitors. Another possible point of debate is the change from annual to biennial election of board officers and the altered voting status of ex officio members, which may affect governance control and institutional influence.

Impact

The bill amends Virginia law governing the Virginia Commonwealth University Health System Authority by revising §§ 23.1-2402 and 23.1-2403. It changes the board’s size, membership categories, appointment authority, term lengths, and leadership selection rules, thereby altering the statutory framework for oversight and administration of the Authority and its health system operations.

Sentiment

No committee transcripts or vote records were provided, so there is no documented floor or committee debate to gauge opposition or support. Based on the enacted text, the measure appears to have been treated as a governance restructuring bill with a generally neutral or favorable reception, rather than a highly contentious policy proposal.

Contention

The main areas of potential contention are the reduction in board membership, the decrease in physician-faculty representation, and the redistribution of appointment authority among state and university actors. Stakeholders concerned with university influence, faculty input, or independent oversight could view these changes differently, especially given the requirement that a majority of board members remain unaffiliated with the University or Authority.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.